Furthermore, combining the S-phase-specific chemotherapeutic gemcitabine with CX3CR1 cell ablation resulted in additional attenuation of tumor progression.<h4>Conclusions</h4>CX3CR1-expressing mononuclear cells invade the TME after radiation therapy in a mouse lung cancer model. The gene discussed is CX3CR1; the disease is lung cancer.